Understanding Social Drivers of Health, Burden, and Impact of Hidradenitis Suppurativa among Different Racial and Ethnic Groups in the USA [0.03%]
美国不同种族和族群里关于汗腺炎的社会驱动因素、疾病负担及影响的理解
Tarannum Jaleel,Raj Chovatiya,Elizabeth D Bacci et al.
Tarannum Jaleel et al.
Introduction: Hidradenitis suppurativa (HS), an inflammatory skin disorder characterized by painful nodules and abscesses, has varying prevalence among different races/ethnicities. This study explored the social drivers o...
A Narrative Review: Do Systemic Drugs Used in the Treatment of Psoriatic Disease Affect Alzheimer's Disease? [0.03%]
叙事性回顾：用于治疗银屑病的系统性药物会影响阿尔茨海默病吗？
Jin-Hui Chen,Tsen-Fang Tsai
Jin-Hui Chen
Various comorbidities have been associated with psoriasis. Most clinical studies support the hypothesis that psoriasis may be a risk factor for dementia. Meanwhile, some evidence indicates that certain immunomodulatory agents, many of which...
Development and Validation of the Visual Medical Scale to Evaluate Nail Psoriasis Severity (ViSENPsO®) [0.03%]
视觉医学量表的开发和验证用于评估指甲银屑病严重程度（ViSENPsO®）
Adilson DaCosta,Cláudio de Lélis Filgueiras de Souza,Renan Minotto et al.
Adilson DaCosta et al.
Introduction: A reliable, well-defined measure of fingernail psoriasis severity for clinical trials is an unmet need. The objective of this study was to develop and validate the Visual Medical Scale to Evaluate Nail Psori...
Collagen, Curcumin, and Glutathione to Enhance Dermal Health in Aging Women with Declining Estrogen Levels -A Narrative Review [0.03%]
雌激素下降的衰老女性利用胶原蛋白、姜黄素和谷胱甘肽改善皮肤健康的功效-综述性文章
Priscila Abex,Edwin D Lephart
Priscila Abex
Nutraceuticals represent promising strategies for preventing, delaying and addressing premature aging of the skin, especially as women advance in years (particularly after 30 years of age, when estrogen levels begin to decline, and remarkab...
Summary of Research: Immunogenicity of Dupilumab in Adult and Pediatric Patients with Atopic Dermatitis [0.03%]
Dupixent（杜匹鲁单抗）过敏性研究综述：成人及儿童特应性皮炎患者注射后的免疫原性反应
Matthew P Kosloski,Ching-Ha Lai,Michael A Partridge et al.
Matthew P Kosloski et al.
of the original article "Immunogenicity of Dupilumab in Adult and Pediatric Patients with Atopic Dermatitis." Dupilumab is a monoclonal antibody used to treat atopic dermatitis (AD) in patients 6 months and older. Antibody drugs can induce ...
A Prebiotic and Panthenol-Containing Repair Balm Improves Tolerability of Topical 5-Fluorouracil Field Therapy for Actinic Keratoses: A Randomised Controlled Trial [0.03%]
一项随机对照试验：一种含益生元和泛醇的修复膏剂可改善 topical 5-氟尿嘧啶治疗光化性角化病的耐受性
Anne Tseng,Regina Yu,Susan Brown et al.
Anne Tseng et al.
Introduction: Topical 5-fluorouracil (5-FU) is an effective field therapy for actinic keratoses (AKs) with proven chemopreventive benefit; however, treatment-limiting local skin reactions frequently impair tolerability an...
Epigenetic Skin Aging and Its Reversal to Improve Skin Longevity across Ethnicities and Phototypes Using a Dihydromyricetin-Containing Serum: Results from a Prospective, Single-Cohort Study [0.03%]
表观遗传皮肤老化及其逆转：使用含二氢杨梅素的护肤液改善不同人种和肤色类型皮肤寿命的前瞻性单一队列研究报告
Minyue Qi,Paula Pitta,Katrin Wegner et al.
Minyue Qi et al.
Introduction: Skin aging is driven by intrinsic and extrinsic factors. Epigenetic alterations are one primary hallmark of aging and powerful biomarkers of biological skin age. To investigate epigenetic skin aging mechanis...
Clinical Laboratory Parameters in Adolescents with Moderate-to-Severe Atopic Dermatitis Treated with Tralokinumab Up to Week 52 in the Phase 3 ECZTRA 6 Trial [0.03%]
第3阶段ECZTRA 6研究中，度普利尤单抗治疗中至重度特应性皮炎青少年患者长达52周的临床实验室指标变化
Amy S Paller,Michael J Cork,H Chih-Ho Hong et al.
Amy S Paller et al.
Introduction: Tralokinumab is approved for the treatment of moderate-to-severe atopic dermatitis (AD) in patients aged ≥ 12 years. Here, we examined clinical laboratory parameters in adolescents with moderate-to-severe A...
Treatment Patterns and Economic Burden in Moderate to Severe Chronic Hand Eczema in the USA: A Real-World Retrospective Claims Analysis [0.03%]
美国中重度慢性手湿疹的治疗模式和经济负担：一项真实世界的回顾性索赔分析
April W Armstrong,Rebecca Burne,Aseel Bin Sawad et al.
April W Armstrong et al.
Introduction: Although Chronic Hand Eczema (CHE) is associated with substantial humanistic burden, treatment patterns and economic impact are poorly understood in the USA. Therefore, this study characterized real-world tr...
Tildrakizumab Improves Disease Severity and Patient-Reported Outcomes in Moderate-to-Severe Chronic Plaque Psoriasis: A Prospective Real-World Study [0.03%]
特立德珠单抗改善中重度慢性斑块状银屑病患者的疾病严重程度和患者报告结果：一项前瞻性真实世界研究
Paola Facheris,Francesco Piscazzi,Giovanni Fiorillo et al.
Paola Facheris et al.
Introduction: Chronic plaque psoriasis significantly impairs physical, psychological, and social well-being. Patient-reported outcome measures (PROMs) are increasingly recognized as essential endpoints. Tildrakizumab, an ...